TREATMENT OF PERIPHERAL VASCULAR DISEASE USING UMBILICAL CORD TISSUE-DERIVED CELLS

PROBLEM TO BE SOLVED: To provide techniques of treating a patient having a peripheral vascular disease with umbilical derived cells and fibrin glue.SOLUTION: A kit for treating a patient having a peripheral vascular disease comprises fibrinogen, thrombin and an isolated homogenous population of cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NUR ISRAEL, SRIDEVI DHANARAJ, MEIDLER ROBERTO, ROEE ATLAS, BAR LILIANA, ANTHONY J KIHM, CHARITO S BUENSUCESO
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NUR ISRAEL
SRIDEVI DHANARAJ
MEIDLER ROBERTO
ROEE ATLAS
BAR LILIANA
ANTHONY J KIHM
CHARITO S BUENSUCESO
description PROBLEM TO BE SOLVED: To provide techniques of treating a patient having a peripheral vascular disease with umbilical derived cells and fibrin glue.SOLUTION: A kit for treating a patient having a peripheral vascular disease comprises fibrinogen, thrombin and an isolated homogenous population of cells obtained from human umbilical cord tissue in an amount effective to treat the disease. The umbilical cord tissue is substantially free of blood. The isolated homogenous population of cells is capable of self-renewal and expansion in culture, has the potential to differentiate and do not express CD117 and/or telomerase.SELECTED DRAWING: None 【課題】臍帯由来細胞及びフィブリン糊で、末梢血管疾患を有する患者の治療を行う技術を開示する。【解決手段】末梢血管疾患を有する患者を治療するためのキットであって、フィブリノーゲン、トロンビン、及び、ヒト臍帯組織から得られた均質な単離細胞集団を、該疾患の治療に有効な量で含み、該臍帯組織は、実質的に血液を含まず、かつ、該均質な単離細胞集団は、培養時に自己複製能及び増殖能を示し、分化する潜在能力を有し、かつCD117及び/又はテロメラーゼを発現しない、キット。【選択図】 なし
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2016135791A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2016135791A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2016135791A3</originalsourceid><addsrcrecordid>eNqNy7EKwjAQgOEuDqK-w-FeMBYVxzO52kjahrukaykSJ9FCfX_s4AM4_cv3LzMOTBhqagK0JXhi6ytidNCh6OiQwVghFIIotrlCrC_WWT0D3bKBYEUi5Wb-OjKgyTlZZ4vH8JzS5tdVti0p6CpP47tP0zjc0yt9-pvf79RRFYfTWWHxF_oCQL8wJw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREATMENT OF PERIPHERAL VASCULAR DISEASE USING UMBILICAL CORD TISSUE-DERIVED CELLS</title><source>esp@cenet</source><creator>NUR ISRAEL ; SRIDEVI DHANARAJ ; MEIDLER ROBERTO ; ROEE ATLAS ; BAR LILIANA ; ANTHONY J KIHM ; CHARITO S BUENSUCESO</creator><creatorcontrib>NUR ISRAEL ; SRIDEVI DHANARAJ ; MEIDLER ROBERTO ; ROEE ATLAS ; BAR LILIANA ; ANTHONY J KIHM ; CHARITO S BUENSUCESO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide techniques of treating a patient having a peripheral vascular disease with umbilical derived cells and fibrin glue.SOLUTION: A kit for treating a patient having a peripheral vascular disease comprises fibrinogen, thrombin and an isolated homogenous population of cells obtained from human umbilical cord tissue in an amount effective to treat the disease. The umbilical cord tissue is substantially free of blood. The isolated homogenous population of cells is capable of self-renewal and expansion in culture, has the potential to differentiate and do not express CD117 and/or telomerase.SELECTED DRAWING: None 【課題】臍帯由来細胞及びフィブリン糊で、末梢血管疾患を有する患者の治療を行う技術を開示する。【解決手段】末梢血管疾患を有する患者を治療するためのキットであって、フィブリノーゲン、トロンビン、及び、ヒト臍帯組織から得られた均質な単離細胞集団を、該疾患の治療に有効な量で含み、該臍帯組織は、実質的に血液を含まず、かつ、該均質な単離細胞集団は、培養時に自己複製能及び増殖能を示し、分化する潜在能力を有し、かつCD117及び/又はテロメラーゼを発現しない、キット。【選択図】 なし</description><language>eng ; jpn</language><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES ; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR ; HUMAN NECESSITIES ; HYGIENE ; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES ; MEDICAL OR VETERINARY SCIENCE ; METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160728&amp;DB=EPODOC&amp;CC=JP&amp;NR=2016135791A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160728&amp;DB=EPODOC&amp;CC=JP&amp;NR=2016135791A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NUR ISRAEL</creatorcontrib><creatorcontrib>SRIDEVI DHANARAJ</creatorcontrib><creatorcontrib>MEIDLER ROBERTO</creatorcontrib><creatorcontrib>ROEE ATLAS</creatorcontrib><creatorcontrib>BAR LILIANA</creatorcontrib><creatorcontrib>ANTHONY J KIHM</creatorcontrib><creatorcontrib>CHARITO S BUENSUCESO</creatorcontrib><title>TREATMENT OF PERIPHERAL VASCULAR DISEASE USING UMBILICAL CORD TISSUE-DERIVED CELLS</title><description>PROBLEM TO BE SOLVED: To provide techniques of treating a patient having a peripheral vascular disease with umbilical derived cells and fibrin glue.SOLUTION: A kit for treating a patient having a peripheral vascular disease comprises fibrinogen, thrombin and an isolated homogenous population of cells obtained from human umbilical cord tissue in an amount effective to treat the disease. The umbilical cord tissue is substantially free of blood. The isolated homogenous population of cells is capable of self-renewal and expansion in culture, has the potential to differentiate and do not express CD117 and/or telomerase.SELECTED DRAWING: None 【課題】臍帯由来細胞及びフィブリン糊で、末梢血管疾患を有する患者の治療を行う技術を開示する。【解決手段】末梢血管疾患を有する患者を治療するためのキットであって、フィブリノーゲン、トロンビン、及び、ヒト臍帯組織から得られた均質な単離細胞集団を、該疾患の治療に有効な量で含み、該臍帯組織は、実質的に血液を含まず、かつ、該均質な単離細胞集団は、培養時に自己複製能及び増殖能を示し、分化する潜在能力を有し、かつCD117及び/又はテロメラーゼを発現しない、キット。【選択図】 なし</description><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</subject><subject>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7EKwjAQgOEuDqK-w-FeMBYVxzO52kjahrukaykSJ9FCfX_s4AM4_cv3LzMOTBhqagK0JXhi6ytidNCh6OiQwVghFIIotrlCrC_WWT0D3bKBYEUi5Wb-OjKgyTlZZ4vH8JzS5tdVti0p6CpP47tP0zjc0yt9-pvf79RRFYfTWWHxF_oCQL8wJw</recordid><startdate>20160728</startdate><enddate>20160728</enddate><creator>NUR ISRAEL</creator><creator>SRIDEVI DHANARAJ</creator><creator>MEIDLER ROBERTO</creator><creator>ROEE ATLAS</creator><creator>BAR LILIANA</creator><creator>ANTHONY J KIHM</creator><creator>CHARITO S BUENSUCESO</creator><scope>EVB</scope></search><sort><creationdate>20160728</creationdate><title>TREATMENT OF PERIPHERAL VASCULAR DISEASE USING UMBILICAL CORD TISSUE-DERIVED CELLS</title><author>NUR ISRAEL ; SRIDEVI DHANARAJ ; MEIDLER ROBERTO ; ROEE ATLAS ; BAR LILIANA ; ANTHONY J KIHM ; CHARITO S BUENSUCESO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2016135791A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2016</creationdate><topic>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</topic><topic>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NUR ISRAEL</creatorcontrib><creatorcontrib>SRIDEVI DHANARAJ</creatorcontrib><creatorcontrib>MEIDLER ROBERTO</creatorcontrib><creatorcontrib>ROEE ATLAS</creatorcontrib><creatorcontrib>BAR LILIANA</creatorcontrib><creatorcontrib>ANTHONY J KIHM</creatorcontrib><creatorcontrib>CHARITO S BUENSUCESO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NUR ISRAEL</au><au>SRIDEVI DHANARAJ</au><au>MEIDLER ROBERTO</au><au>ROEE ATLAS</au><au>BAR LILIANA</au><au>ANTHONY J KIHM</au><au>CHARITO S BUENSUCESO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREATMENT OF PERIPHERAL VASCULAR DISEASE USING UMBILICAL CORD TISSUE-DERIVED CELLS</title><date>2016-07-28</date><risdate>2016</risdate><abstract>PROBLEM TO BE SOLVED: To provide techniques of treating a patient having a peripheral vascular disease with umbilical derived cells and fibrin glue.SOLUTION: A kit for treating a patient having a peripheral vascular disease comprises fibrinogen, thrombin and an isolated homogenous population of cells obtained from human umbilical cord tissue in an amount effective to treat the disease. The umbilical cord tissue is substantially free of blood. The isolated homogenous population of cells is capable of self-renewal and expansion in culture, has the potential to differentiate and do not express CD117 and/or telomerase.SELECTED DRAWING: None 【課題】臍帯由来細胞及びフィブリン糊で、末梢血管疾患を有する患者の治療を行う技術を開示する。【解決手段】末梢血管疾患を有する患者を治療するためのキットであって、フィブリノーゲン、トロンビン、及び、ヒト臍帯組織から得られた均質な単離細胞集団を、該疾患の治療に有効な量で含み、該臍帯組織は、実質的に血液を含まず、かつ、該均質な単離細胞集団は、培養時に自己複製能及び増殖能を示し、分化する潜在能力を有し、かつCD117及び/又はテロメラーゼを発現しない、キット。【選択図】 なし</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2016135791A
source esp@cenet
subjects CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES
DISINFECTION, STERILISATION, OR DEODORISATION OF AIR
HUMAN NECESSITIES
HYGIENE
MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES
MEDICAL OR VETERINARY SCIENCE
METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TREATMENT OF PERIPHERAL VASCULAR DISEASE USING UMBILICAL CORD TISSUE-DERIVED CELLS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A14%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NUR%20ISRAEL&rft.date=2016-07-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2016135791A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true